Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives. Quick Links Investor Presentation Responsibility News Portfolio Responsibility Report Annual Reports Leadership Governance SEC Filings Latest Press Releases October 10, 2024 Incyte Furthers Commitment to People Living with Atopic Dermatitis by Sharing Additional Patient Experiences as part of its Moments of Clarity Program October 8, 2024 Incyte to Report Third Quarter Financial Results October 7, 2024 Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) All press releases Latest Events Oct 29 2024 Oct 29 2024 Q3 2024 Incyte Corporation Earnings Conference Call Click here for Webcast Sep 19 2024 Sep 19 2024 Cantor Global Healthcare Conference Click here for Webcast All events